Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    20494267 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Atomoxetine for Attention Deficit Hyperactivity Disorder in Adolescents With Substance Use Disorder
Conditions: Attention Deficit Hyperactivity Disorder;   Substance Abuse
Intervention: Drug: Atomoxetine

Indicates status has not been verified in more than two years